TESA (Tesamorelin) is a growth hormone–releasing hormone (GHRH) analog commonly studied for its role in stimulating the body’s natural production of growth hormone. In research settings, TESA is recognized for its targeted action on the pituitary gland, supporting regulated and sustained growth hormone signaling.

This peptide is frequently explored for its potential to:

• Promote natural growth hormone release
• Support metabolic and endocrine system research
• Assist in studies involving body composition and energy balance
• Contribute to tissue maintenance and recovery pathways

TESA is valued in research for its ability to mimic endogenous signaling, making it a key compound in studies focused on optimizing hormone regulation and downstream effects.

Key Features:

• Single-peptide GHRH analog
• Targeted growth hormone pathway support
• High-purity lyophilized powder
• Consistent and reliable for research applications